A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders

被引：71
|
作者：
Schmidt, DW [1 ]
Bremner, T [1 ]
Orris, JJ [1 ]
Maier, DB [1 ]
Benadiva, CA [1 ]
Nulsen, JC [1 ]
机构：
[1] Univ Connecticut, Ctr Hlth, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil,Ctr Adv Reprod S, Farmington, CT 06030 USA
来源：
FERTILITY AND STERILITY | 2005年 / 83卷 / 05期
关键词：
D O I：
10.1016/j.fertnstert.2004.10.053
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Forty-eight patients who met the criteria of poor response during prior gonadotropin stimulation were enrolled in a randomized prospective study comparing a gonadotropin-releasing hormone (GnRH) antagonist protocol, using ganirelix acetate, with a microdose GnRH agonist protocol for in vitro fertilization-embryo transfer (IVF-ET). This pilot study contributes to the literature of poor response IVF treatment protocols because the use of ganirelix appears to be as effective as the microdose protocol and may be a superior choice in terms of cost and convenience for the patient. (Fertil Steril (R) 2005;83:1568-71. (c) 2005 by American Society for Reproductive Medicine.)
引用
收藏
页码：1568 / 1571
页数：4
相关论文
共 50 条
  • [1] A randomized, prospective study of microdose leuprolide vs. ganirelix in IVF cycles for poor response patients.
    Schmidt, DW
    Bremner, T
    Orris, JJ
    Maier, DB
    Benadiva, CA
    Nulsen, JC
    FERTILITY AND STERILITY, 2002, 78 (03) : S19 - S20
  • [2] A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders
    DiLuigi, Andrea J.
    Engmann, Lawrence
    Schmidt, David W.
    Benadiva, Claudio A.
    Nulsen, John C.
    FERTILITY AND STERILITY, 2011, 95 (08) : 2531 - 2533
  • [3] Microdose leuprolide versus ganirelix in "poor responder" patients.
    Orris, JJ
    Nulsen, JC
    Benadiva, CA
    Maier, DB
    FERTILITY AND STERILITY, 2001, 76 (03) : S233 - S234
  • [4] A randomized, prospective study of microdose leuprolide versus oocyte donation in poor response patients.
    Kanzepolsky, LS
    de Fried, EP
    FERTILITY AND STERILITY, 2003, 80 : S192 - S192
  • [5] Natural cycle versus microdose gonadotropin-releasing hormone analogue flare cycles in poor responders who undergo in vitro fertilization
    Schimberni, M
    Giallonardo, A
    Piscitelli, C
    Giannini, P
    Morgia, F
    Sbracia, M
    Aragona, C
    Human Reproduction, 2005, : 617 - 622
  • [6] In vitro fertilization following natural cycles in poor responders
    Feldman, B
    Seidman, DS
    Levron, J
    Bider, D
    Shulman, A
    Shine, S
    Dor, J
    GYNECOLOGICAL ENDOCRINOLOGY, 2001, 15 (05) : 328 - 334
  • [7] A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization
    Morgia, F
    Sbracia, M
    Schimberni, M
    Giallonardo, A
    Piscitelli, C
    Giannini, P
    Aragona, C
    FERTILITY AND STERILITY, 2004, 81 (06) : 1542 - 1547
  • [8] GNRH ANTAGONIST/LETROZOLE VERSUS MICRODOSE GNRH AGONIST FLARE PROTOCOL IN POOR RESPONDERS UNDERGOING IN VITRO FERTILIZATION
    Davar, Robab
    Oskouian, Homa
    Ahmadi, Shahnaz
    Firouzabadi, Razieh Dehghani
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2010, 49 (03): : 297 - 301
  • [9] Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill?
    Elassar, Alyaa
    Nulsen, John
    Engmann, Lawrence
    Benadiva, Claudio
    JOURNAL OF REPRODUCTIVE MEDICINE, 2015, 60 (5-6) : 199 - 204
  • [10] Microdose flare versus antagonist for poor responders
    Meldrum, David R.
    Schoolcraft, William
    FERTILITY AND STERILITY, 2010, 93 (07) : E35 - E35
12345